ABSTRACT
Currently, more and more people are suffering from chronic kidney disease (CKD). It is estimated that CKD affects over 10% of the population worldwide. This is a significant issue, as the kidneys largely contribute to maintaining homeostasis by, among other things, regulating blood pressure, the pH of blood, and the water-electrolyte balance and by eliminating unnecessary metabolic waste products from blood. What is more, this disease does not show any specific symptoms at the beginning. The development of CKD is predisposed by certain conditions, such as diabetes mellitus or hypertension. However, these disorders are not the only factors promoting the onset and progression of CKD. The primary purpose of this review is to examine renin-angiotensin-aldosterone system (RAAS) activity, transforming growth factor-ß1 (TGF-ß1), vascular calcification (VC), uremic toxins, and hypertension in the context of their impact on the occurrence and the course of CKD. We firmly believe that a deeper comprehension of the cellular and molecular mechanisms underlying CKD can lead to an enhanced understanding of the disease. In the future, this may result in the development of medications targeting specific mechanisms involved in the decline of kidney function. Our paper unveils the selected processes responsible for the deterioration of renal filtration abilities.
Subject(s)
Disease Progression , Renal Insufficiency, Chronic , Renin-Angiotensin System , Humans , Renal Insufficiency, Chronic/pathology , Renal Insufficiency, Chronic/metabolism , Renin-Angiotensin System/physiology , Animals , Hypertension/physiopathology , Hypertension/pathology , Vascular Calcification/metabolism , Vascular Calcification/pathology , Vascular Calcification/physiopathology , Transforming Growth Factor beta1/metabolism , Kidney/pathology , Kidney/metabolism , Kidney/physiopathologySubject(s)
Ketamine , Mental Disorders , Consciousness/drug effects , Healthy Volunteers , Humans , Ketamine/pharmacology , PsychopathologyABSTRACT
INTRODUCTION: Treatment with fixed orthodontic appliances requires the application of adhesive systems to enable secure fastening of brackets and retainers to the surface of tooth enamel. The orthodontic bonding systems are similar in terms of chemical composition to dental filling materials, the chemical stability of which is not satisfactory. Particularly alarming is the release of bisphenol A and its derivatives to the external environment, which has been well-documented for materials used in conservative dentistry. OBJECTIVES: The aim of the study was an in vitro assessment of the release of biologically harmful bisphenol A and its derivatives from orthodontic adhesives available on the European market, as a potential health risk factor for orthodontic patients. MATERIAL AND METHODS: The study assessed levels of BPA, BPA polymers and Bis-GMA resin in eluates of six commonly used orthodontic adhesives: Light Bond, Transbond XT, Resilence, Aspire, GrenGloo and ConTec LC, obtained after one hour, 24 hours, 7 days and 31 days of material sample storage in water. The presence and concentration of the studied chemicals in the obtained solutions were identified using the HPLC method. RESULTS: The highest (p≤0.05) concentration of BPA at 32.10µg/ml was observed in the Resilence material eluates. The highest concentration of poly-bisphenol A was found in solutions obtained after incubation of ConTec LC adhesive at 371.90µg/ml, whereas the highest amount of Bis-GMA resin (425.07µg/ml) was present in Aspire material eluates. CONCLUSIONS: 1) In conditions of the current experiment it was demonstrated that most of the assessed orthodontic adhesive resins available on the European market and released into the outside environment - biologically harmful bisphenol A or its derivatives, posing a potential threat to the patients' health. 2) Release of BPA and its derivatives into aqueous solutions is the highest in the early stages of sample incubation.
